Why this ASX stock is a 'compelling value play'

Value investors might want to check out this share that Bell Potter is bullish on.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are looking for good value ASX stocks, then read on.

That's because Bell Potter has just named one stock as a "compelling value play."

A businessman hugs his computer and smiles.

Image source: Getty Images

Which ASX stock?

The stock that the broker is recommending to clients is Select Harvests Ltd (ASX: SHV).

It is an integrated grower, processor, and marketer of almonds, owning and operating farming and processing assets in Australia.

Bell Potter highlights that recent developments in the important Californian almond growing region could give the ASX stock a boost. It said:

The implementation of the Sustainable Groundwater Management Act (SGMA) in California has the potential to result in a multi-year reduction in Californian almond supply, kickstarting an upward price cycle that would be materially beneficial for SHV.

The affected acreage: California produces ~77% of global almonds and supplies ~83% of global exports. Counties deemed in chronically overdrafted basins account for ~80% Californian almonds production. The implementation of sustainability plans in 2020, looks to be already reducing yields and as we approach 2040, there remains the scope for an acceleration in orchard removals to reach sustainability targets.

In light of this, the broker sees Australia as a logical supply hub. It adds:

First derivative winners are established almond producers (and SHV is the best ASX listed exposure). But there is also likely to be a reallocation of capital towards Australian assets and this could create a growth narrative for SHV that is missing. This would likely be through development of new orchards and/or expanded third party processing and marketing opportunities. There would also likely be favourable gains in orchard values.

Should you invest?

According to the note, the broker has retained its buy rating and $5.30 price target on the ASX stock.

Based on its current share price of $3.89, this implies potential upside of 36% for investors over the next 12 months.

In addition, Bell Potter is expecting a 2.5% dividend yield over the period, boosting the total potential return beyond 38%.

Commenting on its investment thesis, the broker said:

While yields and prices are volatile year-to-year, we see the key implication being a long-duration upswing in the commodity value first and asset values second. Trading at a 28% discount to market NAV and 5.4x FY26e EBITDA we see SHV as a compelling value play on what could be one of the best global plays on a SGMA.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

Morgans tips a 600%+ return for this ASX biotech stock

Good clinical study progress has the broker bullish on this company.

Read more »

Wlorker on a laptop on top of solar panels.
Broker Notes

Up 8%, should I buy the rebound in Origin Energy shares today?

A leading analyst provides his forecast for Origin Energy’s rebounding shares.

Read more »

A woman stands in a field and raises her arms to welcome a golden sunset.
Gold

4 ASX 200 gold shares to buy: Experts

Experts explain their buy ratings following these miners' June quarter reports.

Read more »

Three balls at various places on a cycle.
Broker Notes

6 ASX uranium shares to buy ahead of yellow cake rising to US$200 per pound: experts

This broker tips 83% to 295% upside over 12 months for its 6 top ASX uranium share picks.

Read more »